CLDI

← Markets

CLDICalidi Biotherapeutics, Inc.

Discussion

Nothing said here yet.

to join the conversation.

—

Thu, Aug 13
3:30 PMYahooCalidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Mon, Jul 27
7:00 AMYahooCalidi Biotherapeutics Presents New Data on Cytotoxicity and IL-15 SA Expression in Human and Murine Tumor Cells at the American Association for Cancer Research Drug Discovery and Development Conference
Tue, Jul 21
7:00 AMYahooCalidi Biotherapeutics Provides Mid-Year Corporate Update and Future Key Value Drivers
Wed, Jul 8
3:05 PMYahooCalidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711
Wed, Jun 24
7:00 AMYahooCalidi Biotherapeutics Presents New Data on CLD-501, Its In Situ T-Cell Engager Candidate Targeting TROP-2 at the T-Cell Engager Therapeutic Summit
Tue, Jun 23
7:00 AMYahooCalidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors
Tue, Jun 16
7:00 AMYahooCalidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Study
Mon, Jun 8
7:00 AMYahooCalidi Biotherapeutics Announces Investor Webinar on June 9, 2026
Fri, Jun 5
11:00 AMYahooJoin Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on June 9
Tue, May 26
7:00 AMYahooCalidi Biotherapeutics Announces Online Abstract Acceptances at the 2026 ASCO Annual Meeting
Fri, May 22
5:00 PMYahooCalidi Biotherapeutics Provides Required NYSE American Disclosure
Thu, May 14
3:10 PMYahooCalidi Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Operational Highlights